These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37013673)

  • 21. Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking.
    Ma HY; Xie GY; Tao J; Li ZZ; Liu P; Zheng XJ; Wang RP
    BMC Cardiovasc Disord; 2024 Jan; 24(1):29. PubMed ID: 38172720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incremental value of Late Gadolinium Enhancement by Cardiac MRI in risk stratification of heart failure patients with moderate and severe LV dysfunction.
    Kolluru L; Srikala J; Rao HN; Maheen S; Rao BH
    Indian Heart J; 2021; 73(1):49-55. PubMed ID: 33714409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Cardiac-MRI Scar Heterogeneity Combined With Left Ventricular Strain in Patients With Myocardial Infarction.
    Zhao X; Zhao X; Jin F; Wang L; Zhang L
    J Magn Reson Imaging; 2023 Aug; 58(2):466-476. PubMed ID: 36377611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.
    Tanaka H; Tatsumi K; Matsuzoe H; Matsumoto K; Hirata KI
    Cardiovasc Diabetol; 2020 Jun; 19(1):84. PubMed ID: 32534593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy.
    Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
    Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
    JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events.
    Mikami Y; Cornhill A; Heydari B; Joncas SX; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Yee R; Merchant N; Lydell CP; Howarth AG; White JA
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):82. PubMed ID: 27839514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis.
    Chevalier C; Kremer K; Cavus E; Schneider J; Jahnke C; Schön G; Radunski UK; Tahir E; Adam G; Lund G; Kirchhof P; Blankenberg S; Muellerleile K
    Open Heart; 2022 Dec; 9(2):. PubMed ID: 36522125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
    Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of myocardial fibrosis on left ventricular torsion and twist in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T; Gürel E; Tigen K; Güler A; Dündar C; Fotbolcu H; Basaran Y
    Cardiol J; 2013; 20(3):276-86. PubMed ID: 23788302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of diabetes mellitus on left ventricular function and deformation in patients with restrictive cardiomyopathies: a 3.0T CMR feature tracking study.
    Gao Y; Jiang YN; Shi R; Guo YK; Xu HY; Min CY; Yang ZG; Li Y
    Cardiovasc Diabetol; 2023 Nov; 22(1):317. PubMed ID: 37985989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of Myocardial Deformation in Patients with Takayasu Arteritis by Cardiovascular Magnetic Resonance Feature Tracking Imaging.
    Zhang H; Zhao L; Zhang C; Tian J; Ding Y; Zhao X; Ma X
    J Magn Reson Imaging; 2022 Jun; 55(6):1828-1840. PubMed ID: 34582063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study.
    Li XM; Shi K; Jiang L; Wang J; Yan WF; Gao Y; Shen MT; Shi R; Zhang G; Liu XJ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jun; 23(1):217. PubMed ID: 38915040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement.
    Spartera M; Damascelli A; Mozes F; De Cobelli F; La Canna G
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1351-1360. PubMed ID: 28299606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.